SONOMA BIOTHERAPEUTICS
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.
SONOMA BIOTHERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.sonomabio.com
Total Employee:
101+
Status:
Active
Total Funding:
335 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Kyverna Therapeutics
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Opsin Biotherapeutics
Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Piper Sandler
Piper Sandler investment in Series B - Sonoma BioTherapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Sonoma BioTherapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Sonoma BioTherapeutics
Ally Bridge Group
Ally Bridge Group investment in Series B - Sonoma BioTherapeutics
Deep Track Capital
Deep Track Capital investment in Series B - Sonoma BioTherapeutics
Mirae Asset Global Investments
Mirae Asset Global Investments investment in Series B - Sonoma BioTherapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Sonoma BioTherapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Sonoma BioTherapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Sonoma BioTherapeutics
Lifeforce Capital
Lifeforce Capital investment in Series B - Sonoma BioTherapeutics
Key Employee Changes
Official Site Inspections
http://www.sonomabio.com Semrush global rank: 1.72 M Semrush visits lastest month: 13.85 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sonoma BioTherapeutics"
About | Sonoma Biotherapeutics
Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by …See details»
Our Values In Action | Sonoma Biotherapeutics
Collaborative We believe that innovation requires the collaboration of many people working together, and the most critical insights can come from anyone in the organization. We will …See details»
Sonoma Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical …
Feb 24, 2025 Sonoma Biotherapeutics is a business that specializes in creating adoptive Treg therapies for autoimmune and degenerative diseases. The company employs next-generation …See details»
Sonoma Biotherapeutics - LinkedIn
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers ...See details»
Sonoma Biotherapeutics - Crunchbase Company …
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on …See details»
Sonoma Therapeutics - VentureRadar
"Sonoma Biotherapeutics is an immune tolerance company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an …See details»
Sonoma Bio Co-Founder and Chief Executive Officer
May 4, 2023 Sonoma Biotherapeutics is based in South San Francisco and Seattle. For more information visit sonomabio.com and follow on Twitter and LinkedIn.See details»
Who We Are | Sonoma Biotherapeutics
Everyone at SonomaBio has a rich and diverse history. It’s one of the things that makes us who we are.See details»
Sonoma Biotherapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for Sonoma Biotherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Sonoma Biotherapeutics - 2025 Company Profile - Tracxn
Aug 17, 2021 Sonoma Biotherapeutics - Developer of T-cell-based therapies for autoimmune and degenerative diseases. Raised a total funding of $335M over 3 rounds from 22 investors.See details»
Director, Program and Alliance Management - Cell Therapy
4 days ago Join or sign in to find your next job Join to apply for the Director, Program and Alliance Management - Cell Therapy role at Sonoma BiotherapeuticsSee details»
Working At Sonoma Biotherapeutics: Company Overview and …
2020 Website www.sonomabio.com Organization Type Private Social Media Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for …See details»
Sonoma Biotherapeutics Company Profile | Management and
Find contact information for Sonoma Biotherapeutics. Learn about their Research & Development, Business Services market share, competitors, and Sonoma Biotherapeutics's email format.See details»
Sonoma Biotherapeutics Appoints Leaders in Cell Therapy and …
Apr 11, 2023 Sonoma Biotherapeutics is based in South San Francisco and Seattle. For more information visit sonomabio.com and follow on Twitter and LinkedIn .See details»
People & Culture | Sonoma Biotherapeutics
Sonoma Bio is founded and led by pioneers in T reg biology and cell therapy. This is their life’s work and they’re building an equally passionate and collaborative team to execute on …See details»
Sonoma BioTherapeutics - Craft
Sonoma BioTherapeutics is a company that develops a regulatory T-cell therapy for autoimmune and degenerative diseases. The company uses genome editing and targeted cell therapy to …See details»
Overview, News & Similar companies - ZoomInfo.com
Nov 6, 2023 View Sonoma Biotherapeutics (www.sonomabio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Careers | Sonoma Biotherapeutics
To external Recruiters or Talent Acquisition Agencies: If you would like to supply candidate resumes to Sonoma Biotherapeutics, please work directly through SonomaBio’s Talent …See details»
Sonoma Biotherapeutics Company Overview, Contact Details
Mar 28, 2023 Learn more about Sonoma Biotherapeutics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Our Concept | Sonoma Biotherapeutics
Restoring balance to the immune system is the key to unlocking the cure for autoimmune diseases. SonomaBio is the only company addressing both sides of immune balance.See details»